Rostock A, Hoffmann W, Siegemund C, Bartsch R
Department of Research and Development, VEB Pharmazeutisches Kombinat GERMED Dresden, GDR.
Methods Find Exp Clin Pharmacol. 1989 Sep;11(9):547-53.
The effect of three anticonvulsants on several test methods for evaluation of memory-enhancing drugs have been studied in rats and mice. The results were compared to the results obtained from the nootropic piracetam and from imipramine. In an active avoidance test (pole jumping), repeated administration of carbamazepine (5 mg/kg i.p.) and piracetam (300 mg/kg p.o.) protected against impairment of learning rate caused by repeated application of an electroconvulsive shock. Valproate calcium (repeated administration of 30 mg/kg i.p.) was only weakly active, while clonazepam (repeated administration of 0.3 mg/kg i.p.) decreased the learning rate even more. Drugs were given in dosages which have no anticonvulsive activity in this test. The impairment of learning rate caused by repeated application of ethanol was prevented by carbamazepine (5 mg/kg i.p.), valproate calcium (30 and 100 mg/kg i.p.) and piracetam (100 mg/kg i.p.). Clonazepam (0.3 and 1 mg/kg i.p.) had a worsening effect on learning rate. In Porsolt's behavioral despair test, carbamazepine (5, 10 and 30 mg/kg i.p.) and valproate calcium (30 and 100 mg/kg i.p.) shortened the duration of immobility, which indicates an increased psychomotor activity. Clonazepam was ineffective. Results obtained with carbamazepine are similar to those obtained with piracetam. The data are discussed in view of the so-called psychotropic effects of carbamazepine in clinical trials.
在大鼠和小鼠中研究了三种抗惊厥药对几种评估记忆增强药物的测试方法的影响。将结果与从促智药吡拉西坦和丙咪嗪获得的结果进行了比较。在主动回避试验(跳杆试验)中,重复给予卡马西平(5毫克/千克腹腔注射)和吡拉西坦(300毫克/千克口服)可防止因重复施加电惊厥休克而导致的学习率受损。丙戊酸钙(重复给予30毫克/千克腹腔注射)活性较弱,而氯硝西泮(重复给予0.3毫克/千克腹腔注射)甚至使学习率降低得更多。给药剂量在此试验中无抗惊厥活性。卡马西平(5毫克/千克腹腔注射)、丙戊酸钙(30和100毫克/千克腹腔注射)和吡拉西坦(100毫克/千克口服)可防止因重复给予乙醇而导致的学习率受损。氯硝西泮(0.3和1毫克/千克腹腔注射)对学习率有恶化作用。在波索尔特行为绝望试验中,卡马西平(5、10和30毫克/千克腹腔注射)和丙戊酸钙(30和100毫克/千克腹腔注射)缩短了不动时间,这表明精神运动活性增加。氯硝西泮无效。卡马西平获得的结果与吡拉西坦获得的结果相似。鉴于卡马西平在临床试验中的所谓精神otropic效应讨论了这些数据。